you mean they don't have one ???? OMG.....what a "great " management team ! hopefully that person will be told that "the stock is all locked up". I wonder if our little cheerleader can find her pom-poms and search the internet for candidate.
" oh you mean they don't have one ?". No little Timmy they don't have one yet. It's a GROWING company with 48 employees and soon to have 49. Ha ha ha ha. Your comments are hilarious. You actually think PhDs of that calibre grow on trees???? Go ahead little Timmy . Throw in your application !!!! No they don't have one yet because the current management team at this point are multitasking as the company is growing. The reason I cut and paste the info on this board is obvious. It's like the company giving the execs raises and bonuses and more stock.
ITS BECAUSE THEY ARE CONFIDENT AND ARE PROCEEDING FORWARD AND WANT TO KEEP, GROW, And DEVELOP A STRONG AND WORTHY MANAGEMENT TEAM !!
The position is responsible for the third party management of the sterile formulation development, scale up, technology transfer and clinical manufacturing of Threshold’s late-stage, lead drug product candidate - TH-302. The active – TH-302 is a hypoxia activated prodrug in Phase 3 development for the treatment of soft tissue sarcoma and pancreatic cancer. Scale up and transferring the manufacturing process to commercial scale along with writing of the regulatory CMC sections will be expected. In addition, the position is responsible for the establishment of pre-formulation and small scale parenteral formulation capabilities internally at Threshold.
The position provides an opportunity for a candidate to leverage their strong technical, formulation development, problem solving expertise and to gain experience in the areas of late stage development, scale up, and NDA filing.
The candidate will be working on CMC-related activities in collaboration with our development partner – Merck Sereno - on global registration of TH-302. -THLD
Hey Timmy , check it out !! " GLOBAL REGISTRATION ", and " NDA filing ". Sorry dude, I think a PhD is required.
A Ph.D. in Pharmaceutical Sciences, Chemical Engineering, or Chemistry with 2 to 5 years experience in sterile formulations development.
Experience in lyophilization cycle development is desired.
The successful candidate must have excellent communications (written and verbal) skills; ability to communicate cross-functionally.
The position may travel from 10 to 25% of the time. -THLD
Looks like their looking for another heavy hitter .
YUP! You need a PhD. Sorry timmy, I guess you're out . Too bad though, looks like the position would be traveling GLOBALLY 10 to 25% of the time. Could be fun !!